Theresa Heggie
Director · BIOCRYST PHARMACEUTICALS INC
- 2025
- Jun 15, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Theresa Heggie files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alane P. Barnes - $3.46M in BCRX purchases and sales in the last 12 months
- Amy E. McKee - $100K in BCRX purchases and sales in the last 12 months
- Machelle Sanders - $69K in BCRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Theresa Heggie?
Theresa Heggie is a corporate insider, tracked as Director of BIOCRYST PHARMACEUTICALS INC (BCRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Theresa Heggie last file a Form 4?
The most recent primary Form 4 on record is dated 15 June 2026, one of 3 filings going back to 2025.
Has Theresa Heggie been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.10M) across all tracked filings.
